August 2, 2016 Vincent Conklin President Lyotropic Therapeutics, Inc. 10962 Richardson Road Suite H Ashland, VA 23005 Re: Letter Agreement Regarding Royalty Payments Dear Vince:Letter Agreement Regarding Royalty Payments • March 15th, 2017 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
We refer to that certain License and Sublicense Agreement between Lyotropic Therapeutics, Inc. (“Lyotropic”) and Eagle Pharmaceuticals, Inc. (“Eagle”) dated October 16, 2008 (the “Eagle License Agreement”) and that certain License Agreement between Elan Pharma International Ltd. (“Elan”) and Lyotropic dated August 17, 2004 (the “Elan License Agreement”). All capitalized terms used but not otherwise defined herein shall have the meaning set forth in the Eagle License Agreement. This Letter Agreement shall become effective on the date of the last signature below (the “Effective Date”)
